Skip Navigation

Profile

Jeffrey Rogers, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

43 Ratings
12 Comments
 

Jeffrey Rogers, M.D.

Program Director, Surgical Sciences-Transplant
Professor, err

Clinical Interests

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, General Surgery, Transplant Surgery

Contact Information

Returning Patient Appointments: 336-716-0548
Department: 336-716-0548

Email: jerogers@wakehealth.edu

Insurance Accepted »

Education & Training

  • B.A., University of Pennsylvania, 1986
  • M.D., Albert Einstein College of Medicine, 1990
  • Residency, Montefiore Hosp/Med Ctr, 1995
  • Fellowship, Transplant Surgery, Univ of Pitt Sch of Medicine, 1996
  • Fellowship, Transplantation Immunology, Univ of Pitt Sch of Medicine, 1997
  • Fellowship, Transplant Surgery, Univ of Pitt Sch of Medicine, 1999

Board Certifications

  • American Board of Surgery, Surgery

NPI Number

  • 1073598140
Jeffrey Rogers, M.D.

Doctor Rating

4.7 out of 5

43 Ratings
12 Comments
 

Jeffrey Rogers, M.D.

Program Director, Surgical Sciences-Transplant
Professor, err
Institute for Regenerative Medicine

Research Interests

Kidney Transplantation; Pancreas Transplantation; Tissue Donors; Kidney Failure, Chronic; Graft Survival
More »

Contact Information

Academic: 336-716-0548 | Department: 336-716-0548

Email: jerogers@wakehealth.edu

Recent Publications

Kidney exchange to overcome financial barriers to kidney transplantation. Rees MA, Dunn TB, Kuhr CS, Marsh CL, Rogers J, Rees SE, Cicero A, Reece LJ, Roth AE, Ekwenna O, Fumo DE, Krawiec KD, Kopke JE, Jain S, Tan M, Paloyo SR.. Am J Transplant. 2017;17(3):782-790.

Global kidney exchange [abstract]. Rees M, Dunn T, Rees S, Rogers J, Reece L, Roth A, Kuhr C, Ekwenna O, Fumo D, Krawiec K, Jain S, Marsh C, Cicero A, Kopke J, Tan M, Paloyo S.. Am J Transplant. 2017;17(Suppl 2):60.

Should ECD kidneys be used in retransplantation? [abstract]. Alradawna B, Khan M, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2017;17(Suppl 2):51.

Severe intellectual disability is not a contraindication to kidney transplantation in children. Chen A, Farney A, Russell GB, Nicolotti L, Stratta R, Rogers J, Lin JJ.. Pediatr Transplant. 2017;21(3):e12887.

Lack of utility of KDPI in dual kidneys from donors at the extremes of age [abstract]. McCullough MA, Khan M, Alradawna B, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2017;17(Suppl 2):47.

Clinical yield of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration for incidental pancreatic cysts in kidney transplant evaluation. Rejeski J, Rogers J, Hauser M, Mishra G.. Clin Transplant. 2017;31(7):e12999.

Analysis of local versus imported expanded criteria donor kidneys: a single-center experience with 497 ECD kidney transplants. Khan MA, El-Hennawy H, Farney AC, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta RJ.. Clin Transplant. 2017;31(8):e13029.

Lack of utility of KDPI in dual kidneys from donors at the extremes of age [abstract]. Felts D, Khan M, Alradawna B, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Doares W, Kaczmorski S, Stratta J.. Am J Transplant. 2017;17(Suppl 3):443-444.

Kidney re-transplantation (KRTx) from donation after cardiocirculatory death (DCD)-standard criteria donors (SCD) [abstract]. Khan M, Alradawna B, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Doares W, Kaczmorsky S, Stratta R.. Am J Transplant. 2017;17(Suppl 3):625.

Global kidney exchange [abstract]. Rees M, Dunn T, Rees S, Rogers J, Roth A, Kuhr C, Ekwenna O, Krawiec K, Jain S, Marsh C, Sindhwani P, Zimmerman M, Forbes R, Tan M, Ashlagi I, Correa-Rotter R, Paloyo S.. Am J Transplant. 2017;17(Suppl 3):812.

Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair. Rogers J, Katari R, Gifford S, Tamburrini R, Edgar L, Voigt MR, Murphy SV, Igel D, Mancone S, Callese T, Colucci N, Mirzazadeh M, Peloso A, Zambon JP, Farney AC, Stratta RJ, Orlando G.. Expert Rev Clin Immunol. 2016;12(2):169-182.

The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new-generation bioartificial endocrine pancreas. Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas ME, Sordi V, Citro A, Purroy C, Niu G, McQuilling JP, Sittadjody S, Farney AC, Iskandar SS, Zambon JP, Rogers J, Stratta RJ, Opara EC, Piemonti L, Furdui CM, Soker S, De Coppi P, Orlando G.. Ann Surg. 2016;264(1):169-179.

APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND,.. Transplantation. 2016;100(1):194-202.

Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? [abstract]. Carrier A, Kahn MA, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):43.

Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard [abstract]. Jones K, Khan A, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):44.

Differential effect of delayed graft function on kidney transplant outcomes [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Brim E, Hairston G, Mangus M, Stratta R.. Am J Transplant. 2016;16(Suppl 1):53.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Stratta R.. Am J Transplant. 2016;16(Suppl 1):54.

Single vs dual (en bloc) kidney transplants from donors less than or equal to 5 years of age: a single center experience. Al-Shraideh Y, Farooq U, El-Hennawy H, Farney AC, Palanisamy A, Rogers J, Orlando G, Khan M, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. World J Transplant. 2016;6(1):239-248.

Single-center experience with deceased donor kidney transplantation in 114 individuals aged 70 and older in the new millennium [letter]. Stratta RJ, Farney AC, Palanisamy A, Rogers J, Orlando G, Reeves-Daniel A.. J Am Geriatr Soc. 2016;64(11):e219-e221.

Why are pancreas transplants declining in the United States in the past decade? [abstract]. Stratta R, Gruessner A, Odorico J, Fridell J, Rogers J, Farney A, Orlando, G, Gruessner R.. Am J Transplant. 2016;16(Suppl 3):518.

Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? [abstract]. Khan M, Carrier A, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):300.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Islandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):399.

Differential effect of delayed graft function (DGF) on kidney transplant outcomes: when does DGF not make a difference? [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):738-739.

Influence of pancreas import and cold ischemia on outcomes following pancreas transplantation [abstract]. Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2016;16(Suppl 3):421.

Pediatric en bloc kidney transplants reduce DGF and are misrepresented by the KDPI [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):568.

Outcomes of deceased donor kidney transplantation from diabetic donors: does presence of recipient diabetes matter? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, El-Hennawy H, Khan M, Gautreaux M, Iskandar S Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):569-570.

Managing the kidney waiting list: pride and prejudice [abstract]. Smith F, Sheehan C, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2016;16(Suppl 3):629.

Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard [abstract]. Khan M, Jones K, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 3):569.

Does donor and recipient age disparity make a difference with expanded criteria donors? [abstract]. Khan M, Jones K, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):627.

Role of allograft nephrectomy following kidney graft failure: preliminary experience with pre-operative angiographic kidney embolization. Al-Geizawi SM, Singh RP, Zuckerman JM, Requarth JA, Farney AC, Rogers J, Taussig J, Orlando G, Stratta RJ.. J Nephrol. 2015;28(3):379-385.

Simultaneous transplantation of the living donor kidney and deceased donor pancreas and other transplant options for diabetic and uremic patients. Farney AC, Rogers J, Orlando G, Stratta RJ.. Curr Opin Organ Transplant. 2015;20(1):103-107.

Does prolonged cold ischemia influence outcomes following pancreas transplantation? [abstract]. El Hennawy H, Rogers J, Farney A, Orlando G, Kahn M, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2015;15(Suppl 1):112.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. El Hennawy H, Farney A, Orlando G, Rogers J, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Stratta R.. Am J Transplant. 2015;15(Suppl 1):75.

Prospect for kidney bioengineering: shortcomings of the status quo. Peloso A, Katari R, Murphy SV, Zambon JP, DeFrancesco A, Farney AC, Rogers J, Stratta RJ, Manzia TM, Orlando G.. Expert Opin Biol Ther. 2015;15(4):547-558.

Discarded human pancreas as source of ECM scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Peloso A, Katari R, Urbani L, Maghsoudlou P, Fallas MEA, Citro A, Delario G, Willis C, Farney A, Rogers J, Stratta R, Peimonti L, Soker S, Orlando G.. Am J Transplant. 2015;15(Suppl 1):49.

Pancreas transplantation in C-peptide positive patients: does 'type' of diabetes really matter?. Stratta RJ, Rogers J, Farney AC, Orlando G, El-Hennawy H, Gautreaux MD, Reeves-Daniel A, Palanisamy A, Iskandar SS, Bodner JK.. J Am Coll Cardiol. 2015;220(4):716-727.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL,.. Am J Transplant. 2015;15(6):1615-1622.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW,.. Kidney Int. 2015;88(3):584-592.

Donor-derived myeloid sarcoma in two kidney transplant recipients from a single donor. Palanisamy A, Persad P, Koty PP, Douglas LL, Stratta RJ, Rogers J, Reeves-Daniel AM, Orlando G, Farney AC, Beaty MW, Pettenati MJ, Iskandar SS, Grier DD, Kaczmorski SA, Doares WH, Gautreaux MD, Freedman BI, Powell BL.. Case Rep Nephrol. 2015;2015():821346.

The human pancreas as a source of pro-tolerogenic extracellular matrix scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Peloso A, Orlando G, Urbani L, Cravedi P, Sordi V, Guoguang N, Citro A, Mcquilling J, Farney A, Iskandar S, Rogers J, Stratta R, Opara E, Piemonti L, Soker S, De Coppi P, Petrosyan A.. Tissue Eng Part A. 2015;21(Suppl 1):S141.

The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new generation bioartificial endocrine pancreas [abstract]. Orlando G, Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas EMA, Sordi V, Purroy C, Niu GG, Mcquilling JP, Sivanandane S, Farney AC, Iskandar SS, Rogers J, Stratta RJ, Opara EC, Piemonti L, Soker S, De Coppi P.. Transpl Int. 2015;28(Suppl 4):129.

Pancreas transplantation with portal venous drainage with an emphasis on technical aspects. Rogers J, Farney AC, Orlando G, Farooq U, Al-Shraideh Y, Stratta RJ.. Clin Transplant. 2014;28(1):16-26.

Single versus dual (en bloc) kidney transplants from donors less than 5 years of age: a single center experience [abstract]. Al-Shraideh Y, Farney A, Rogers J, Orlando G, Farooq U, Stratta R.. Am J Transplant. 2014;14(Suppl 2):72.

Is recipient BMI greater than or equal to 40 a contraindication to kidney transplantation? [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74-75.

Effect of donor obesity on outcomes in expanded criteria donor kidney transplantation [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74.

Does high recipient BMI influence outcomes in deceased donor kidney transplantation? A paired donor kidney analysis [abstract]. Farooq U, Alshraideh Y, Orlando G, Rogers J, Farney A, Stratta R.. Am J Transplant. 2014;14(Suppl 2):74.

Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective. Stratta RJ, Farney AC, Rogers J, Orlando G.. Expert Rev Clin Immunol. 2014;10(1):117-132.

Primary non function after deceased donor kidney transplantation: risks and consequences [abstract]. Al-Shraideh Y, Stratta R, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Bodner J, Uloko V, Winfrey S, Kaczmorski S, Doares W, Mangus M, Gautreaux M, Iskandar S, Rogers J.. Transplantation. 2014;98(Suppl 1):631.

Single center analysis of outcomes in 202 consecutive pancreas transplants according to different measures of success [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):855.

Pancreas transplantation in C-peptide positive patients: does type of diabetes really matter? [abstract]. Bodner J, Farney A, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Reeves-Daniel A, Palanisamy A, Stratta R.. Transplantation. 2014;98(Suppl 1):864.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, err

Clinical Interests

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, General Surgery, Transplant Surgery
Jeffrey Rogers, M.D.

Jeffrey Rogers, M.D.

Program Director, Surgical Sciences-Transplant
Professor, err
Institute for Regenerative Medicine

Doctor Rating

4.7 out of 5

Jeffrey Rogers, M.D.43 Ratings
12 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.7
CP efforts to include in decisions
4.6
CP explanations of prob/condition
4.7
CP spoke using clear language
4.7
Friendliness/courtesy of CP
4.7
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.7
Time CP spent with patient
4.7
Wait time at clinic
4.3



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

8/24/2017

*Dr. Rogers was great!

8/3/2017

All the persons work well together and keep the patients welfare first - always.

7/26/2017

Good.

7/24/2017

No bad.

6/27/2017

*Dr. Jeffrey Rogers is a very good doctor. *Dr. Rogers demonstrated excellence.

6/16/2017

*Dr. Rogers is the best.

5/31/2017

One of the best doctors I've ever ______ to.

5/31/2017

Exceptional! Very professional.

4/25/2017

*Dr. Rogers is the only doctor I will see with problems with my transplanted kidney.

3/23/2017

Best care ever!

3/20/2017

Extremely impressed, these doctors are very skillful and knowledgeable.

12/12/2016

I would recommend *Dr. Rogers to anyone.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Six Wake Forest Baptist Specialties Earn U.S. News RankingsComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsMagnet Hospital RecognitionJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.